Literature DB >> 22014885

Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations.

Noémi Anikó Bartha1, József Sóki, Edit Urbán, Elisabeth Nagy.   

Abstract

In this study, the antibiotic susceptibilities to tigecycline and tetracycline of 35 selected Bacteroides fragilis group strains were determined by Etest, and the presence of tetQ, tetX, tetX1 and ermF genes was investigated by polymerase chain reaction (PCR). tetQ was detected in all 12 B. fragilis group isolates (100%) exhibiting elevated tigecycline minimum inhibitory concentrations (MICs) (≥ 8 μg/mL) as well as the 8 strains (100%) with a tigecycline MIC of 4 μg/mL, whilst tetX and tetX1 were present in 15% and 75% of these strains, respectively. All of these strains were fully resistant to tetracycline (MIC ≥ 16 μg/mL). On the other hand, amongst the group of strains with tigecycline MICs< 4 μg/mL (15 isolates), tetQ, tetX and tetX1 were found less frequently (73.3%, 13.3% and 46.7%, respectively). All but two strains harbouring the tetQ gene in this group were non-susceptible to tetracycline, with a MIC> 4 μg/mL. These data suggest that in most cases tigecycline overcomes the tetracycline resistance mechanisms frequently observed in Bacteroides strains. However, the presence of tetX and tetX1 genes in some of the strains exhibiting elevated MICs for tigecycline draws attention to the possible development and spread of resistance to this antibiotic agent amongst Bacteroides strains. The common occurrence of ermF, tetX, tetX1 and tetQ genes together predicted the presence of the CTnDOT-like Bacteroides conjugative transposon in this collection of Bacteroides strains.
Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014885     DOI: 10.1016/j.ijantimicag.2011.07.010

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  18 in total

Review 1.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature.

Authors:  E Urbán
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

3.  Co-occurrence of Plasmid-Mediated Tigecycline and Carbapenem Resistance in Acinetobacter spp. from Waterfowls and Their Neighboring Environment.

Authors:  Chao-Yue Cui; Chong Chen; Bao-Tao Liu; Qian He; Xiao-Ting Wu; Ruan-Yang Sun; Yan Zhang; Ze-Hua Cui; Wen-Ying Guo; Qiu-Lin Jia; Cang Li; Barry N Kreiswirth; Xiao-Ping Liao; Liang Chen; Ya-Hong Liu; Jian Sun
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 4.  Time for Some Group Therapy: Update on Identification, Antimicrobial Resistance, Taxonomy, and Clinical Significance of the Bacteroides fragilis Group.

Authors:  Sophonie Jean; Miranda J Wallace; Gautam Dantas; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2022-06-14       Impact factor: 11.677

5.  Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates.

Authors:  David R Snydman; Laura A McDermott; Nilda V Jacobus; Kathryn Kerstein; Trudy H Grossman; Joyce A Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

6.  Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital.

Authors:  Mei Deng; Man-Hua Zhu; Jun-Jie Li; Sheng Bi; Zi-Ke Sheng; Fei-Shu Hu; Jia-Jie Zhang; Wei Chen; Xiao-Wei Xue; Ji-Fang Sheng; Lan-Juan Li
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

7.  Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate.

Authors:  Liyuan Wang; Dejun Liu; Yuan Lv; Lanqing Cui; Yun Li; Tianmeng Li; Huangwei Song; Yuxin Hao; Jianzhong Shen; Yang Wang; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

8.  Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes.

Authors:  Andrei Nicoli Gebieluca Dabul; Juliana Sposto Avaca-Crusca; Daria Van Tyne; Michael S Gilmore; Ilana Lopes Baratella Cunha Camargo
Journal:  Microb Drug Resist       Date:  2017-10-17       Impact factor: 3.431

9.  Evolution in action: dissemination of tet(X) into pathogenic microbiota.

Authors:  Rustam I Aminov
Journal:  Front Microbiol       Date:  2013-07-10       Impact factor: 5.640

10.  Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes.

Authors:  Aimée M Moore; Sanket Patel; Kevin J Forsberg; Bin Wang; Gayle Bentley; Yasmin Razia; Xuan Qin; Phillip I Tarr; Gautam Dantas
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.